Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ocera Therapeutics OCRX

Healthcare Biotechnology
"Ocera Therapeutics Inc is a clinical-stage biopharmaceutical company. The Company is engaged in the development and commercialization of proprietary compounds to treat acute and chronic orphan liver disease."

Recent & Breaking News (NDAQ:OCRX)

Ocera Therapeutics Announces Appointment of Gaurav Aggarwal, M.D., as Chief Business Officer

GlobeNewswire May 2, 2014

Ocera Therapeutics to Announce First Quarter Financial Results

GlobeNewswire April 29, 2014

Ocera Reports Fourth Quarter and Year-End 2013 Financial Results

GlobeNewswire March 13, 2014

Ocera Therapeutics to Announce Fourth Quarter and Year End Financial Results

GlobeNewswire March 4, 2014

Ocera Therapeutics to Present at the Cowen and Company 34th Annual Health Care Conference

GlobeNewswire February 26, 2014

Ocera Therapeutics Announces Enrollment of the First Patient in a Phase IIb Study for Treatment of Acute Hepatic Encephalopathy

Globe Newswire January 8, 2014

Ocera Therapeutics Announces Election of Wendell Wierenga to Board

Globe Newswire December 24, 2013

Ocera Therapeutics and the Roche Group Enter Into Technology Transfer and License Agreement

Globe Newswire December 17, 2013

Ocera Therapeutics Announces Staffing Transition

Globe Newswire December 11, 2013

Ocera Therapeutics to Present at Piper Jaffrey Healthcare Conference

Globe Newswire November 26, 2013

Ocera Reports Third Quarter Business Update and Financial Results

Globe Newswire November 13, 2013

Ocera Therapeutics Announces $28 Million Private Placement

Globe Newswire November 6, 2013

Neos Therapeutics, Inc. Announces the Appointment of Vipin K. Garg, Ph.D. as Chief Executive Officer and Board Director

Business Wire October 22, 2013

Ocera Therapeutics to Present at BIO Investor on October 8, 2013

Globe Newswire September 25, 2013

Ocera Announces Post-Merger Closure of Quebec Research Site

Globe Newswire September 17, 2013

Jeryl L. Hilleman Joins Ocera Therapeutics as Chief Financial Officer

Globe Newswire September 3, 2013

Ocera Therapeutics Announces Second Quarter 2013 Financial Results

Globe Newswire August 13, 2013

Ocera Therapeutics to Report Second Quarter 2013 Financial Results

Globe Newswire July 26, 2013